Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesEfficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis
Bone , 06/11/09
Jian-min L et al. - There were no clinically relevant changes in laboratory tests, such as blood routine, hepatic and renal function. It is thus concluded that the effects of 2 g/day strontium ranelate on BMD and its safety profile in this cohort of postmenopausal osteoporotic Asian women were consistent with results obtained from Caucasian women in which the efficacy on the reduction in risk of fracture has been proven.
Related Articles
A perspective on male osteoporosis
Best Practice & Research: Clinical Rheumatology, 12/03/09
Relevance Score: 90%
The association between osteoporosis and static balance in elderly women
Osteoporosis International, 11/30/09
Relevance Score: 89%
Urinary cadmium, osteopenia, and osteoporosis in the US population
Osteoporosis International, 11/30/09
Relevance Score: 89%
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09
Relevance Score: 89%
U.S. Hip Fracture Rate Could Drop 25 Percent With Aggressive Osteoporosis Prevention
ScienceDaily, 11/06/09
Relevance Score: 89%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteoporosis risk assessment and ethnicity
Journal of General Internal Medicine, 12/07/09
Hormonal deprivation therapy-induced osteoporosis in postmenopausal women with breast cancer
Best Practice & Research: Clinical Rheumatology, 12/07/09
Monitoring osteoporosis treatment
Best Practice & Research: Clinical Rheumatology, 12/04/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/07/09
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09
In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status
Evidence-Based Medicine, 12/07/09
Sponsor
Article Search
Sponsor